Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-052524
Filing Date
2025-04-09
Accepted
2025-04-09 16:19:55
Documents
2
Period of Report
2025-04-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1555
2 EX-24 vrdn-ex24.htm EX-24 11448
  Complete submission text file 0000950170-25-052524.txt   14795
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
Ajer Jeffrey Robert (Reporting) CIK: 0001557533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36483 | Film No.: 25825459

Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)